Jul. 14 at 10:45 PM
$ABCL
Looking forward, Hansen's foresight continues to anticipate the evolution of antibody therapies. He notes that while the initial multi-billion-dollar market explosion was driven by simple, standard monoclonal antibodies, the future lies in highly engineered formats.
He's stated that "what you're seeing now that's the next wave is bispecific antibodies antibody drug conjugates multispecific antibodies radioisotope antibodies there's a Cambrian explosion of modalities that use the advantages of antibodies in unique ways," predicting that this will be the next massive wave of innovation in therapeutic medicines.
According to management, global therapeutic antibody sales amounted to about
$300 billion in 2025 and the market is expected to grow to over
$500 billion by 2030.
